Abstract:SCN9A gene encodes voltage-gated sodium channel NaV1.7 and is associated with a group of heterogeneous phenotypes. Heterozygous gain-of-function SCN9A mutations have been linked to inherited erythromelalgia (IEM), paroxysmal extreme pain disorder (PEPD), and small-fiber neuropathy (SFN), while recessive loss-of-function SCN9A mutations have been linked to congenital insensitivity to pain (CIP). Recently, a heterozygous SCN9A mutation was found to be responsible for generalized epilepsy with febrile seizures plus (GEFS+) in a large pedigree.1 SCN9A variants have also been suggested as a genetic modifier in SCN1A mutation-associated GEFS+ and a possible susceptibility gene for Dravet syndrome [1Singh N.A. Pappas C. Dahle E.J. Claes L.R. Pruess T.H. De Jonghe P. et al.A role of SCN9A in human epilepsies, as a cause of febrile seizures and as a potential modifier of Dravet syndrome.PLoS Genet. 2009; 5: e1000649Crossref PubMed Scopus (209) Google Scholar, 2Mulley J.C. Hodgson B. McMahon J.M. Iona X. Bellows S. Mullen S.A. et al.Role of the sodium channel SCN9A in genetic epilepsy with febrile seizures plus and Dravet syndrome.Epilepsia. 2013; 54: e122-126Crossref PubMed Scopus (49) Google Scholar]. However, the exact role of SCN9A in seizure disorders is still complicated and debating [[2]Mulley J.C. Hodgson B. McMahon J.M. Iona X. Bellows S. Mullen S.A. et al.Role of the sodium channel SCN9A in genetic epilepsy with febrile seizures plus and Dravet syndrome.Epilepsia. 2013; 54: e122-126Crossref PubMed Scopus (49) Google Scholar]. We report a pedigree diagnosed as GEFS+ with a heterozygous mutation (Q10R) in SCN9A gene. The proband (III:1) was a six-year-old boy, who was born at term after an unremarkable pregnancy and had normal early psychomotor development. He experienced febrile and afebrile seizures for more than 10 times since the age of two. All the seizures presented as generalized tonic-clonic seizures for several minutes. No obvious abnormality was found on neurological examination. Brain MRI and ambulatory EEG were unremarkable. His younger brother (III:2) was two years old. He was also born at term after an unremarkable pregnancy and had normal early psychomotor development. He experienced febrile and afebrile seizures for 3 times at the age of two. In the further pedigree investigation, the proband’s mother (II:2) and grandmother (I:2) both reported febrile seizures in their childhood (Fig. 1). The febrile seizures of the mother (II:2) and grandmother (I:2) remitted spontaneously by the age of ten. There was no other symptom or sign found on the mother (II:2) and grandmother (I:2), except that both of them reported poor memory. To identify the causative gene of this GEFS+ pedigree, genetic test was performed on the proband using a Next-generation sequencing panel containing 480 epilepsy-related genes. A heterozygous missense mutation c.29A > G (p.Q10R) in SCN9A gene (reference transcript: NM_002977) was detected. This mutation was further confirmed by Sanger sequencing, detected in the affected mother (II:2) and brother (III:3), and not detected in the unaffected father (II:3) (Fig. 1) Interestingly, this missense mutation Q10R and another missense mutation in the same amino acid site − c.28C > A (p.Q10K) were previously reported as causative mutations of IEM patients. c.29A > G (p.Q10R) was absent in 200 alleles from normal Chinese controls, which supported it was unlikely to be a polymorphism [[3]Han C. Dib-Hajj S.D. Lin Z. Li Y. Eastman E.M. Tyrrell L. et al.Early- and late-onset inherited erythromelalgia: genotype-phenotype correlation.Brain. 2009; 132: 1711-1722Crossref PubMed Scopus (99) Google Scholar]. After follow-up questioning, none of these four patients (III:1, III:2, II:2 and I:2) reported any easily recognized extreme pain, warmth or redness phenotypes. Other genes associated with febrile seizures and GEFS+ like SCN1A, GABRG2, CPA6, GABRD and SCN1B were also included in the panel and no candidate mutation in these genes was detected. Based on these clinical symptoms, pedigree history and genetic analysis, we proposed that this is a GEFS+ pedigree associated with the Q10R mutation in SCN9A. Clinical heterogeneity is common in genetic diseases. Even affected members in a GEFS+ pedigree with the same SCN1A mutation could present different phenotypes from febrile seizures to Dravet syndrome, a severe epileptic encephalopathy. SCN9A associated phenotypes in human were varied and included IEM, PEPD, SFN and CIP. SCN9A encodes NaV1.7, which is mainly expressed in neurons of the dorsal root ganglia and has preliminarily been classified as a peripheral nervous system channel. However, expression of NaV1.7 in brain (embryonic hippocampal neurons) was also reported and suggested a role in the central nervous system [[4]Mechaly I. Scamps F. Chabbert C. Sans A. Valmier J. Molecular diversity of voltage-gated sodium channel alpha subunits expressed in neuronal and non-neuronal excitable cells.Neuroscience. 2005; 130: 389-396Crossref PubMed Scopus (61) Google Scholar]. A confirmed large pedigree of GEFS+ and several sporadic patients with febrile seizures associated with mutations in SCN9A were reported, which supported seizure disorders as a fifth phenotype of SCN9A. However, the reports about the role of SCN9A in seizure disorders were rare and still debating. Singh et al. suggested SCN9A as a potential modifier gene to Dravet syndrome in patients with SCN1A mutations [[1]Singh N.A. Pappas C. Dahle E.J. Claes L.R. Pruess T.H. De Jonghe P. et al.A role of SCN9A in human epilepsies, as a cause of febrile seizures and as a potential modifier of Dravet syndrome.PLoS Genet. 2009; 5: e1000649Crossref PubMed Scopus (209) Google Scholar]. Mulley et al. found that rare variants in SCN9A were significantly enriched in Dravet syndrome, but damaging variants were similar between Dravet syndrome patients and normal controls, which supported a role for SCN9A in genetic susceptibility to Dravet syndrome [[2]Mulley J.C. Hodgson B. McMahon J.M. Iona X. Bellows S. Mullen S.A. et al.Role of the sodium channel SCN9A in genetic epilepsy with febrile seizures plus and Dravet syndrome.Epilepsia. 2013; 54: e122-126Crossref PubMed Scopus (49) Google Scholar]. Although it seems complicated about the role of SCN9A in Dravet syndrome, the role of SCN9A in autosomal dominant febrile seizures or GEFS+ is simple. A large GEFS+ pedigree associated with SCN9A mutation with a quite high penetrance for about 95% was reported, which suggested a monogenic pattern in GEFS+ [[1]Singh N.A. Pappas C. Dahle E.J. Claes L.R. Pruess T.H. De Jonghe P. et al.A role of SCN9A in human epilepsies, as a cause of febrile seizures and as a potential modifier of Dravet syndrome.PLoS Genet. 2009; 5: e1000649Crossref PubMed Scopus (209) Google Scholar]. However, other febrile seizures or GEFS+ patients associated with SCN9A mutations were almost sporadic or only with one first-degree relative, which can not offer further powerful evidence for the role of SCN9A in autosomal dominant febrile seizures or GEFS+. We report a GEFS+ pedigree including four patients, which was associated with SCN9A mutation. This report further supports that SCN9A mutations are associated with GEFS+ with a monogenic pattern. Interestingly, the causative mutation in our pedigree Q10R and another mutation in the same amino acid site (Q10K) were reported in late-onset (age of 14 and 35 years) IEM patients [[3]Han C. Dib-Hajj S.D. Lin Z. Li Y. Eastman E.M. Tyrrell L. et al.Early- and late-onset inherited erythromelalgia: genotype-phenotype correlation.Brain. 2009; 132: 1711-1722Crossref PubMed Scopus (99) Google Scholar]. To our knowledge, there is no mutation in SCN9A associated with seizure disorders also found in IEM, PEPD, SFN or CIP patients previously. The underlying mechanism of such heterogeneity was still unclear. Functional study using current-clamp revealed that expression of Q10R mutation induced hyperexcitability on dorsal root ganglion neurons, and this increase in excitability was smaller than the change produced by an early-onset (usually before age of 6 years) IEM mutation I848T [[3]Han C. Dib-Hajj S.D. Lin Z. Li Y. Eastman E.M. Tyrrell L. et al.Early- and late-onset inherited erythromelalgia: genotype-phenotype correlation.Brain. 2009; 132: 1711-1722Crossref PubMed Scopus (99) Google Scholar]. A genotype-phenotype correlation was proposed that more increased excitability on dorsal root ganglion neurons was associated with earlier onset age of IEM. As SCN9A is also expressed in brain, we speculate that the Q10R mutation also increases the central nervous system excitability and causes the phenotype of seizure disorders. There may be a similar genotype-phenotype correlation that more increased central nervous system excitability is associated with more severe seizure disorders (from febrile seizures to Dravet syndrome). Although the mother and the grandmother were older than 30 years and 50 years respectively, no symptoms of IEM were complained so far. As the hyperexcitability on dorsal root ganglion neurons induced by Q10R was smaller than other mutation like I848T, reduced penetrance of IEM symptoms could be considered to explain the absence of IEM symptoms in our pedigree. On the other hand, most febrile seizures would remit spontaneously with age and might be missed by the IEM, PEPD, SFN and CIP patients and their doctors. It is suggested that IEM, PEPD, SFN and CIP patients with SCN9A mutations should be reinvestigated for their possible history of seizure disorders, which might help to further confirm the role of SCN9A in seizure disorders. This report expands the genotype-phenotype spectrum that the Q10R mutation in SCN9A gene is associated with both IEM and GEFS+, and it affects both peripheral and central nervous systems. The authors declare that they have no conflict of interest. We are indebted to the patient and parents for their generous participation in this study. This study was supported by the National Natural Science Foundation of China (Proj. No. 81600850).

Abstract:Genetic generalized epilepsies (GGEs), also known as idiopathic generalized epilepsies, were characterized by recurring generalized seizures in the absence of detectable brain lesion 1. Recently, a study using genome-wide association analysis (GWAS) technology identified five new susceptibility loci which may be associated with GGEs 2. In their study, a two-stage GWAS research was conducted in 3020 GGEs patients and 3954 controls of Europe ancestry. In the end, they got the conclusion that there is significant association for GGEs at 2p16.1 (rs13026414) and 17q21.32 (rs72823592), and suggestive association at 2q24.3 (rs11890028). What's more, they also found significant evidence for association with GAEs at 2q22.3 (rs10496964) and for JME at 1q43 (rs12059546) 2. High-ranking candidate genes of the above five loci are CHRM3, VRK2, ZEB2, SCN1A, and PNPO. The previous studies on the genetics of GGEs mainly concentrate on ion channel genes 3. However, there are increasing interests in the role of novel nonion channel genes that causing GGEs 4. The GWAS mentioned before is one of the studies that focusing on novel common susceptibility genes of GGEs; yet, independent replications were needed. Our study is just to verify whether these five loci are associated with GGEs in Chinese population. Furthermore, we aimed to investigate whether these SNPs play a role in the efficacy of antiepileptic drugs (AEDs). Our study includes 484 Chinese epileptic patients treated with AEDs (298males and 186 female, mean age: 18.3 ± 12.1 years) of Xiangya hospital of Central South University. 2. In total, 284 age-sex matched healthy controls (184 males and 100 female, mean age: 18.6 ± 12.2 years) were enrolled from volunteers. Diagnosis and classification of epilepsy was made according to the International League against Epilepsy guidelines 5. Drug resistant is defined as at least four seizures occurred during a year with the treatment of three or more AEDs at the maximum tolerated dosage 6. While the patients who were free of any type of seizures for a minimum of one year are considered to be drug responsive 7. Genotyping of the five SNPs was performed using MALDI-TOF-MS. Statistical analysis was conducted using SPSS (Version 13.0 for Windows; SPSS, Chicago, IL, USA). Hardy–Weinberg equilibrium was tested for each SNP in the studied samples. We compared the allele and genotype frequencies between patients and controls using chi-square test, the same as the allele and genotype frequencies between responders and nonresponders. Statistical significance was accepted when P < 0.05. The GGEs subgroups comprised 185(38.4%) childhood absence epilepsy (CAE), 95(19.4%) juvenile absence epilepsy (JAE), 124(25.6%) juvenile myoclonic epilepsy (JME), and 80(16.5%) generalized tonic-clonic seizures (EGTCS). The study patients taken all kinds of AEDs, among them carbamazepine, valproic acid, and oxcarbazepine were the most widely used drugs. The genotype distributions of the five SNPs were all consistent with Hardy–Weinberg equilibrium both in GGEs patients and controls. There was no significant difference in alleles or genotypes frequencies of the five SNPs between GGEs patients and controls (Table 1). In addition, we also analyzed allele and genotype frequencies of 5 SNPs in GGEs subtypes (each GGEs subtype and GAEs) and healthy controls, no significant difference was found. We examined the difference of the 5 SNPs' allele and genotype frequencies between drug-responsive patients and drug-resistant patients, respectively (Table 2). However, there seems to be no significant difference. Interestingly, we found that rs11890028 allele and genotype frequency was significantly different between drug-responsive patients and drug-resistant patients both in JAE group (P = 0.002, P = 0.005) and JME group (P = 0.005, P = 0.021). Genome-wide association analysis is being utilized as a powerful technique to search genetic factors that contribute to the cause of common epilepsy syndromes. To date, there are limited GWAS studies that performed in epilepsy patients, even less in GGEs patients specifically 8. The first GWAS study of GGEs patients that come from Europe was conducted in 2012, and five susceptible loci were found 2. In this study, we aimed to test their finding in Chinese GGEs patients, and thus to evaluate whether these five loci are also associate with the vulnerability to GGEs in Chinese population. We genotyped these five SNPs in 484 GGEs patients and 284 healthy controls, and none of these SNPs were found to be related with the occurrence of GGEs. Furthermore, we investigated the association between that five SNPs and AEDs efficacy in 280 drug-responsive patients and 204 drug-resistant patients, but no statistically significant association was found. However, we found that rs11890028 allele and genotype frequency was significantly different between drug-responsive patients and drug-resistant patients both in JAE group and JME group. The polymorphism rs11890028 located nearby the SCN1A gene, as SCN1A encodes the large alpha subunit of sodium channel which is the target of many AEDs, for example, valproic acid, and carbamazepine. So this polymorphism may influence the efficacy of antiepileptic drugs. However, because of the small sample size of JAE (95 subjects) and JME (124 subjects) subgroup, the clinical significance of this result should be verified later. Steffen M's GWAS was conducted in European population, and our study was a replicate study performed in Chinese population, because of the ethnic variance, so, we may get the negative results. Epilepsy can be induced by various factors including genetic ones and environmental ones. And a single nucleotide polymorphism can't explain the whole aspects of the cause of epilepsy 9. Besides, the complexity in the phenotype of epilepsy also accounts 10. Thus, we were trying to find more accuracy method to define the phenotypes of epilepsy. To elucidate the inner connection between GGEs subtypes and genetic factor, we analyzed the subtypes of GGEs, but no significant association was found between GGEs subtypes susceptibility and the five SNPs. However, as mentioned before our study sample size is relative small, especially for the GGEs subtype patients, this is also a reason why we have not replicated their GWAS results. To date, the genesis of epilepsy hadn't been elucidated well yet, and it is caused by polygenic-environment interactions. Thus, the real causes of epilepsy in certain patient remain unknown. Moreover, the evaluation criteria of AEDs efficacy is not normalized and unified. And the relative small sample size also accounts for. Besides, the GWAS linkage data do not resolve to individual genes, but rather large genomic regions. All of the above reasons limited the results of most association researches. In conclusion, our data showed that rs13026414, rs72823592, rs11890028, rs10496964, and rs12059546 found by a European population based GWAS study are not associated with the susceptibility of GGEs in Chinese population. However, in considering of the limited sample size of our study, further studies on association identification at large sample size are needed. We thank all subjects who volunteered to participate in this study. This work was supported by the National High-tech R&D Program of China (863 Program) (2012AA02A517), National Natural Science Foundation of China (81173129, 81202595, 81373490), Program for the Special Scientific Research Foundation of Doctor Disciplines in University of Ministry of Education of China (20110162110034), and Hunan Provincial Natural Science Foundation of China (12JJ7006). The authors declare no conflict of interest.

Evidence for a Major Susceptibility Locus at 11q22.1–23.3 Has Been Detected in a Large Chinese Family with Pure Grand Mal Epilepsy

Q10R Mutation in SCN9A Gene is Associated with Generalized Epilepsy with Febrile Seizures Plus

A Comprehensive Linkage Analysis of Chromosome 21q22 Supports Prior Evidence for A Putative Bipolar Affective Disorder Locus

A Linkage Analysis Between Obsessive Compulsive Spectrum Disorders and Candidate Genes of Group II Metabotropic Glutamate Receptor

Evidence for a Putative Bipolar Disorder Locus on 2p13–16 and Other Potential Loci on 4q31, 7q34, 8q13, 9q31, 10q21–24, 13q32, 14q21 and 17Q11–12

A linkage study of schizophrenia candidate regions in a Chinese multiplex pedigree

Rational Search for Genes in Familial Cortical Myoclonic Tremor with Epilepsy, Clues from Recent Advances.

Q8IYL2 is a Candidate Gene for the Familial Epilepsy Syndrome of Partial Epilepsy with Pericentral Spikes (PEPS)

Genetic Analysis of a Chinese Family Provides Further Evidence for Linkage of Familial Cortical Myoclonic Tremor with Epilepsy to 5P15.31-P15.

SCN1A, SCN1B , and GABRG2 gene mutation analysis in Chinese families with generalized epilepsy with febrile seizures plus

[Analysis of the GABRG2 Gene Mutation in a Chinese Family with Generalized Epilepsy with Febrile Seizures Plus].

Mapping and positional cloning of common idiopathic generalized epilepsies: juvenile myoclonus epilepsy and childhood absence epilepsy

A Novel Genetic Locus for Familial Febrile Seizures and Epilepsy on Chromosome 3Q26.2–q26.33

Genetic analysis in a Chinese BAFME pedigree indicates the possibility of an unidentified locus

Heterozygous PGM3 Variants Are Associated With Idiopathic Focal Epilepsy With Incomplete Penetrance

Partial epilepsy syndrome in a Gypsy family linked to 5q31.3-q32

Genome-Wide Meta-Analysis Identifies Two Novel Risk Loci for Epilepsy

[Clinical Analysis and Screening for SCN1A Gene Mutation in Two Pedigrees of Generalized Epilepsies with Febrile Seizures Plus].

Novel Susceptibility Loci Were Found in Chinese Genetic Generalized Epileptic Patients by Genome-Wide Association Study.

Association of GABRG2 polymorphisms with idiopathic generalized epilepsy.

A Chinese Benign Adult Familial Myoclonic Epilepsy Pedigree Suggesting Linkage to Chromosome 5P15.31–p15.1